Abstract
2-Arylthiomorpholine and 2-arylthiomorpholin-5-one derivatives, designed as rigid and/or non-basic phenylethylamine analogues, were evaluated as rat and human monoamine oxidase inhibitors. Molecular docking provided insight into the binding mode of these inhibitors and rationalized their different potencies. Making the phenylethylamine scaffold rigid by. xing the amine chain in an extended six-membered ring conformation increased MAO-B (but not MAO-A) inhibitory activity relative to the more flexible alpha-methylated derivative. The presence of a basic nitrogen atom is not a prerequisite in either MAO-A or MAO-B. The best K-i values were in the 10(8) M range, with selectivities towards human MAO-B exceeding 2000-fold. (C) 2010 Elsevier Ltd. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 1388-1395 |
Number of pages | 8 |
Journal | Bioorganic & Medicinal Chemistry |
Volume | 18 |
Issue number | 4 |
DOIs | |
Publication status | Published - 15 Feb 2010 |
Keywords
- Monoamine oxidase
- MAO inhibitors
- Arylthiomorpholine derivatives
- Amphetamine
- Human and rat MAO
- Docking
- MAO-B
- BIOLOGICAL-ACTIVITIES
- ALZHEIMERS-DISEASE
- ANALOGS
- INSIGHTS
- INACTIVATION
- RECOGNITION
- SAFINAMIDE
- DOCKING